en fr

About Us
Portfolio and Disease Areas
Investors
News and Events
Contact Us

Nicox Completes Enrolment of NCX 4251 Phase 2 Trial with Top-Line Results on Track for Q4 2019

September 27, 2019

EN_NCX4251_CompleteRecruitment_20190927_F

← Back to blog page

Contact Us
Subscribe to news
Legal Notice

© Copyright Nicox, all rights reserved

Cookies

By continuing to use this website, you agree to our Cookie Policy.